GOSSVSNRIX• 6 Months (Normalized)
GOSS vs NRIX (Gossamer Bio Inc. vs Nurix Therapeutics Inc.)
Showing Closing Date Range from Mar, 15 to Sep, 11, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
GOSS Performance $10.73
+2253.07%
Gossamer Bio Inc.
Normalized Baseline0.00%
NRIX Performance $25.1
+63.2%
Nurix Therapeutics Inc.
Normalized Baseline0.00%
Alpha Spread Margin GOSS LEADS
+2189.87%
GOSS outperforming by 2189.87%
GOSSNRIX
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
GOSS NRIX
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(125 dates)
| Date | GOSS Price | GOSS Gain (%) | NRIX Price | NRIX Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 11, 2026 | $10.73 | +2253.07% | $25.10 | +63.20% | +2189.87% |
| Sep 10, 2026 | $11.36 | +2391.23% | $25.81 | +67.82% | +2323.41% |
| Sep 09, 2026 | $12.80 | +2707.02% | $26.26 | +70.74% | +2636.28% |
| Sep 08, 2026 | $14.40 | +3057.89% | $26.13 | +69.90% | +2987.99% |
| Sep 04, 2026 | $14.00 | +2970.18% | $26.14 | +69.96% | +2900.22% |
| Sep 03, 2026 | $14.05 | +2980.70% | $25.32 | +64.63% | +2916.07% |
| Sep 02, 2026 | $0.17 | -62.06% | $25.82 | +67.88% | -129.94% |
| Sep 01, 2026 | $0.17 | -63.38% | $26.04 | +69.31% | -132.69% |
| Aug 31, 2026 | $0.17 | -62.72% | $25.78 | +67.62% | -130.34% |
| Aug 28, 2026 | $0.17 | -62.72% | $26.21 | +70.42% | -133.14% |
| Aug 27, 2026 | $0.17 | -62.72% | $26.88 | +74.74% | -137.46% |
| Aug 26, 2026 | $0.17 | -61.84% | $26.71 | +73.67% | -135.51% |
| Aug 25, 2026 | $0.21 | -55.04% | $26.95 | +75.23% | -130.27% |
| Aug 24, 2026 | $0.18 | -61.62% | $26.27 | +70.81% | -132.43% |
| Aug 21, 2026 | $0.16 | -66.01% | $26.72 | +73.73% | -139.74% |
Page 1 of 9